myfortic®
(mycophenolic acid) delayed-release tablet is an enteric formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid. This enteric coating ensures that the active moiety is delivered directly to the small intestine without being metabolized in the stomach.

myfortic is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.

Introducing the myKidney Connection program brought to you by myfortic®. The program provides ongoing resources, tools, and financial support information to help your patients manage their post kidney transplant experience.

image1
image1
image1
Click here for complete prescribing information.
medwatch